Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
3.150
+0.060 (1.94%)
At close: Jul 18, 2025, 4:00 PM
3.193
+0.043 (1.37%)
After-hours: Jul 18, 2025, 7:59 PM EDT

Company Description

Pulmonx Corporation, a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.

It offers Zephyr Endobronchial Valve; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.

The company also offers LungTraX Platform, a cloud-based quantitative computed tomography analysis service that provides physicians with multiple products, such as LungTraX Connect to improve workup efficiency; LungTraX Detect to enable patient identification; and StratX Lung report that is designed for solution that includes information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for treatment with Zephyr Valves.

It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.

The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013.

Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Pulmonx Corporation
Pulmonx logo
CountryUnited States
Founded1995
IPO DateOct 1, 2020
IndustryMedical Devices
SectorHealthcare
Employees291
CEOSteven Williamson

Contact Details

Address:
700 Chesapeake Drive
Redwood City, California 94063
United States
Phone650 364 0400
Websitepulmonx.com

Stock Details

Ticker SymbolLUNG
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$19.00
CIK Code0001127537
CUSIP Number745848101
ISIN NumberUS7458481014
SIC Code3841

Key Executives

NamePosition
Steven S. WilliamsonChief Executive Officer, President and Director
Mehul JoshiChief Financial Officer
David A. Lehman J.D.General Counsel and Secretary
Sri RadhakrishnanChief Technical Officer
Marcee M. MaroneyVice President of Marketing
Sarah HuberVice President of Sales (U.S.)
Lisa PaulChief People Officer
Jérôme ErathSenior Vice President and GM of International
Geoffrey Beran RoseChief Commercial Officer
John B. McKuneVice President of Finance and Corporate Controller

Latest SEC Filings

DateTypeTitle
Jun 13, 2025144Filing
Jun 12, 2025144Filing
May 30, 2025SDForm - SD
May 23, 20258-KCurrent Report
May 13, 2025SCHEDULE 13G/AFiling
May 12, 2025SCHEDULE 13G/AFiling
May 7, 2025SCHEDULE 13G/AFiling
May 2, 202510-QQuarterly Report
Apr 30, 20258-KCurrent Report
Apr 24, 2025SCHEDULE 13G/AFiling